首页 News 正文

Merck: Plan to conduct clinical trials of a new multivalent HPV vaccine

胡胡胡美丽_ss
241 0 0

According to Merck, the company recently announced plans to launch a clinical trial of a novel multivalent human papillomavirus (HPV) vaccine aimed at providing broader protection against HPV types. At the same time, Merck plans to conduct other clinical trials to evaluate the protective efficacy and safety of the nine valent human papillomavirus vaccine (brewing yeast) (trade name: Jiada Xiu® 9) single dose vaccination regimen compared to the approved three dose vaccination regimen.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

胡胡胡美丽_ss 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    34